Filing Details

Accession Number:
0001104659-21-082832
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 20:25:58
Reporting Period:
2021-06-15
Accepted Time:
2021-06-17 20:25:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613859 Pra Health Sciences Inc. PRAH Services-Commercial Physical & Biological Research (8731) 463640387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1738327 J. Michael Bonello C/O Pra Health Sciences, Inc.
4130 Parklake Avenue, Suite 400
Raleigh NC 27612
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-15 14,000 $75.81 35,867 No 4 M Direct
Common Stock Acquisiton 2021-06-15 7,123 $81.61 42,990 No 4 M Direct
Common Stock Disposition 2021-06-15 30,279 $168.27 12,711 No 4 S Direct
Common Stock Disposition 2021-06-15 847 $168.80 11,864 No 4 S Direct
Common Stock Acquisiton 2021-06-16 17,216 $81.61 29,080 No 4 M Direct
Common Stock Disposition 2021-06-16 16,316 $166.41 12,764 No 4 S Direct
Common Stock Disposition 2021-06-16 900 $167.49 11,864 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2021-06-15 14,000 $0.00 14,000 $75.81
Common Stock Stock Options (Right to Buy) Disposition 2021-06-15 7,123 $0.00 7,123 $81.61
Common Stock Stock Options (Right to Buy) Disposition 2021-06-16 17,216 $0.00 17,216 $81.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,000 2027-08-29 No 4 M Direct
72,877 2019-04-26 2028-04-26 No 4 M Direct
55,661 2028-04-26 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.69 to $168.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.70 to $168.94, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $167.01, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.10 to $168.04, inclusive.
  6. 4,000 options vested on August 29, 2018; 4,000 options vested on August 29, 2019 and 6,000 options vested on August 29, 2020 upon satisfaction of certain performance criteria.
  7. 12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria.